The Lay Summary – Remember the Reader

Dec 4, 2017

As part of its Clinical Trial Transparency initiative, the EMA mandated a requirement for clinical trial sponsors to prepare a summary of the results of every clinical trial written in language understandable to lay persons (patients and others not in ...

Read More

Challenges with Cash Management and Reforecasting Clinical Trials

Dec 4, 2017

Clinical trials are becoming increasingly complex, particularly with broader scopes, globalisation, changing and expanding regulatory requirements and a greater number of players, such as contract research organisations (CROs), sites, laboratories and vendors. Lorie McClain at Bioclinica discusses the consequences of ...

Read More